Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6 - Klein, Klara R.; Clemmensen, Kim K.B.; Fong, Edwin; Olsen, Søren; Abrahamsen, Trine; Lingvay, Ildiko (Diabetes care, 2024)
Keywords: Adverse events; Agonists; Antidiabetics; Clinical trials; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Gastrointestinal symptoms; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucagon-Like Peptide-1 Receptor - agonists; Glucagon-Like Peptides - adverse effects; Humans; Hypoglycemic Agents - adverse effects; Liraglutide - adverse effects; Metformin; Metformin - adverse effects; Peptides; Receptors; Research design; Titration